The Rise of Hybrid Clinical Trials

Hybrid clinical trial models derive from decentralized clinical trials (DCT), wherein a combination of virtual and in-clinic workflows are implemented to conduct required trial procedures. Nearly all trials operated today are at least partly decentralized trials because they are enabled by technology and virtual workflows. But a hybrid decentralized trial is distinctively different from a fully virtual decentralized trial. Fully virtual trials are completely technology-based, with no traditional site or face-to-face interaction required throughout the duration of the study. Everything from study start-up, patient enrollment, dosing and dispensing, data collection, testing, and final outcomes is managed end-to-end by digital tools and self-administered treatments.